New York A 4100: Establishes an emergency insulin program

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A04100 Summary:

BILL NOA04100 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORCunningham

&nbsp

COSPNSRForrest, Simon

&nbsp

MLTSPNSR

&nbsp

Add Art 28-CC §2894, Pub Health L; add §95-l, St Fin L

&nbsp

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

Go to top A04100 Actions:

BILL NOA04100 

&nbsp

01/31/2025referred to health

01/07/2026referred to health

Go to topA04100 Committee&nbspVotes:

Go to topA04100 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA04100 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4100

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 31, 2025
 ___________

 Introduced by M. of A. CUNNINGHAM, FORREST -- read once and referred to
 the Committee on Health

 AN ACT to amend the public health law and the state finance law, in
 relation to an emergency insulin program

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new article
 2 28-CC to read as follows:
 3 ARTICLE 28-CC
 4 EMERGENCY INSULIN PROGRAM
 5 Section 2894. Emergency insulin program.
 6 § 2894. Emergency insulin program. 1. The commissioner is authorized
 7 and directed to establish an emergency insulin program to ensure that
 8 recipients of the program can access emergency supplies of analog insu-
 9 lins and related supplies. The commissioner shall immediately engage
 10 analog insulin manufacturers to support the state program and facilitate
 11 quick access to affordable analog insulins in emergency situations. The
 12 commissioner shall establish standards for approval of any emergency
 13 insulin program, and analog insulin prescribing, dispensing, distrib-
 14 ution, and possession pursuant to this section which may include, but
 15 not be limited to, standards for program directors, appropriate clinical
 16 oversight, training, record keeping and reporting. The emergency insulin
 17 program shall, pursuant to an appropriation or sufficient funds in the
 18 emergency insulin program trust fund, be available to recipients no
 19 later than April first, two thousand twenty-six.
 20 2. (a) As used in this section:
 21 (i) "Analog insulins" means at a minimum short-acting, rapid-acting,
 22 intermediate and long acting insulin drugs approved by the Food and Drug
 23 Administration that, when administered, to certain recipients are life-
 24 saving, and help avoid serious adverse effects associated with type one

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03543-01-5

 A. 4100 2

 1 diabetes and in some limited cases type two diabetes, and other medica-
 2 tions and supplies approved by the department for such purpose.
 3 (ii) "Health care professional" means a person licensed, registered or
 4 authorized pursuant to title eight of the education law to prescribe
 5 prescription drugs.
 6 (iii) "Pharmacist" means a person licensed or authorized to practice
 7 pharmacy pursuant to article one hundred thirty-seven of the education
 8 law.
 9 (iv) "Recipient" means a person: (1) diagnosed with type one diabetes,
 10 or type two insulin dependent diabetes; and (2) who is at risk of expe-
 11 riencing serious adverse health effects due to a lack of analog insu-
 12 lins; and (3) who is uninsured or underinsured; or (4) an organization
 13 registered as an emergency insulin program pursuant to this section.
 14 (b)(i) A health care professional may prescribe by a patient-specific
 15 or non-patient-specific prescription, dispense or distribute, directly
 16 or indirectly, analog insulins to a recipient.
 17 (ii) A pharmacist may dispense analog insulins, through a patient-spe-
 18 cific or non-patient-specific prescription pursuant to this paragraph,
 19 to a recipient.
 20 (iii) The provisions of this paragraph shall not be deemed to require
 21 a prescription for any analog insulins that do not otherwise require a
 22 prescription; nor shall it be deemed to limit the authority of a health
 23 care professional to prescribe, dispense or distribute, or of a pharma-
 24 cist to dispense, analog insulins